Brewin Dolphin LTD Bio N Tech Se Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2023
BUY
$205.93 - $447.23 $157,536 - $342,130
765 Added 47.28%
2,383 $651 Million
Q2 2021

Nov 09, 2023
BUY
$113.32 - $241.49 $130,091 - $277,230
1,148 Added 244.26%
1,618 $362 Million
Q4 2020

Nov 09, 2023
BUY
$72.71 - $129.54 $5,089 - $9,067
70 Added 17.5%
470 $38.3 Million
Q3 2020

Nov 09, 2023
BUY
$57.81 - $104.17 $23,124 - $41,668
400 New
400 $27.7 Million

Others Institutions Holding BNTX

# of Institutions
327
Shares Held
40.4M
Call Options Held
1.31M
Put Options Held
1.37M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email